The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer

David H. Harpole, Mary Beth Moore, Thomas Aloia, Thomas A. D'Amico, Thomas Sporn, James E. Herndon, Allyson Parr, Ilona Linoila, Carmen Allegra

Research output: Contribution to journalArticlepeer-review

79 Scopus citations

Fingerprint

Dive into the research topics of 'The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences